MedPath

Choroidal Changes Post Short Term Exposure To Virtual Reality Devices

Not Applicable
Withdrawn
Conditions
Myopia
Interventions
Device: Visu
Registration Number
NCT04140877
Lead Sponsor
Visu, Inc.
Brief Summary

This is a prospective, randomized, controlled, contralateral eye, clinical study. The objective of the study is to determine the impact of Virtual Reality (VR) usage on choroidal thickness when viewed through a test display compared to a control (standard) VR display. The hypothesis is that there will be less choroidal thinning in the eye viewing the test VR screen compared to the eye viewing the control VR screen.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Is at least 13 years of age and has full legal capacity to volunteer;
  • Has read and signed an information consent letter;
  • Visual Acuity of +0.20 logMAR or better in each eye;
  • Is willing and able to follow instructions and maintain the appointment schedule.

Key

Exclusion Criteria
  • Is participating in any concurrent clinical or research study;
  • Has any known active ocular disease and/or infection;
  • Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;
  • Is amblyopic in either eye;
  • Has a colour vision abnormality;
  • Commonly experiences motion sickness.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Visu OD, Control OSVisuContralateral eye study
Control OD, Visu OSVisuContralateral eye study
Primary Outcome Measures
NameTimeMethod
Choroidal thickness2 hours
Secondary Outcome Measures
NameTimeMethod
Axial length3 months
Choroidal thickness3 months
© Copyright 2025. All Rights Reserved by MedPath